Lista de obras -

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface

artículo científico publicado en 2022

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

artículo científico publicado en 2017

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease

artículo científico publicado en 2009

Amyloid-β PET and CSF in an autopsy-confirmed cohort

artículo científico publicado en 2020

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly

artículo científico publicado en 2016

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease

artículo científico publicado en 2006

Applying the ATN scheme in a memory clinic population: The ABIDE project

scientific article published on 09 October 2019

Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project

scientific article published on 06 October 2019

Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism

artículo científico publicado en 2007

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers

artículo científico publicado en 2014

Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

artículo científico publicado en 2016

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

artículo científico publicado en 2007

CSF biomarker levels in early and late onset Alzheimer's disease

artículo científico publicado en 2008

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

artículo científico publicado en 2009

Can lumbar puncture help to identify patients with incipient Alzheimer's disease?

artículo científico publicado en 2006

Can post-mortem MRI be used as a proxy for in vivo? A case study

scientific article published on 24 October 2019

Combinations of Service Use Types of People With Early Cognitive Disorders

artículo científico publicado en 2016

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

artículo científico publicado en 2014

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

scientific article published on 08 July 2019

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic

artículo científico publicado en 2014

Diagnostic impact of CSF biomarkers in a local hospital memory clinic

artículo científico publicado en 2010

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

artículo científico publicado en 2017

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.

artículo científico publicado en 2018

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

scholarly article by Arno de Wilde et al published 28 July 2018 in Alzheimers Research & Therapy

Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains

artículo científico publicado en 2015

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project

artículo científico publicado en 2017

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease

artículo científico publicado en 2006

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

artículo científico publicado en 2019

Lumbar puncture in patients with neurologic conditions

artículo científico publicado en 2017

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases

artículo científico publicado en 2016

Optimizing patient care and research: the Amsterdam Dementia Cohort

artículo científico publicado en 2014

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis

artículo científico publicado en 2017

Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project

Reduced cortical thickness in patients with subjective cognitive decline is related to clinical progression

Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2015

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

artículo científico publicado en 2019

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

artículo científico publicado en 2011

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

Survival in memory clinic cohort is short, even in young-onset dementia

artículo científico publicado en 2018

The EMIF-AD PreclinAD study: study design and baseline cohort overview

article by Elles Konijnenberg et al published 4 August 2018 in Alzheimers Research & Therapy

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory

artículo científico publicado en 2017

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline

artículo científico publicado en 2016

Usefulness of Longitudinal Measurements of -Amyloid1-42 in Cerebrospinal Fluid of Patients with Various Cognitive and Neurologic Disorders

artículo científico publicado en 2006

Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements

artículo científico publicado en 2008

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study

artículo científico publicado en 2008

Lista de obras de

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease

Amyloid-β PET and CSF in an autopsy-confirmed cohort

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease

Applying the ATN scheme in a memory clinic population: The ABIDE project

Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project

Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers

Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

CSF biomarker levels in early and late onset Alzheimer's disease

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.

Can lumbar puncture help to identify patients with incipient Alzheimer's disease?

Can post-mortem MRI be used as a proxy for in vivo? A case study

Combinations of Service Use Types of People With Early Cognitive Disorders

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic

Diagnostic impact of CSF biomarkers in a local hospital memory clinic

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Lumbar puncture in patients with neurologic conditions

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases

Optimizing patient care and research: the Amsterdam Dementia Cohort

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis

Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project

Reduced cortical thickness in patients with subjective cognitive decline is related to clinical progression

Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

Survival in memory clinic cohort is short, even in young-onset dementia

The EMIF-AD PreclinAD study: study design and baseline cohort overview

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline

Usefulness of Longitudinal Measurements of -Amyloid1-42 in Cerebrospinal Fluid of Patients with Various Cognitive and Neurologic Disorders

Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study